The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BeOne Medicines Ltd ADR shares valued at $34,620 were sold by Ball Titus B. on Jun 11 ’25. At $258.36 per share, Ball Titus B. sold 134 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Wang Xiaodong sold 41,760 shares, netting a total of over 10,975,316 in proceeds. Following the sale of shares at $262.82 each, the insider now holds 0 shares.
Before that, TITUS BENJAMIN BALL had added 134 shares to its account. In a trade valued at $34,620, the Officer bought BeOne Medicines Ltd ADR shares for $258.36 each.
As published in their initiating research note from RBC Capital Mkts on April 07, 2025, BeOne Medicines Ltd ADR [ONC] has been an Outperform and the price target has been revised to $312. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early March. Earlier on September 18, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for ONC stock.
Analyzing ONC Stock Performance
On last trading session,, BeOne Medicines Ltd ADR [NASDAQ: ONC] rose 5.38% to $276.53. The stock’s lowest price that day was $275.0, but it reached a high of $284.511 in the same session. During the last five days, there has been a surge of approximately 7.60%. Over the course of the year, BeOne Medicines Ltd ADR shares have jumped approximately 49.71%.
Support And Resistance Levels for BeOne Medicines Ltd ADR (ONC)
RSI (Relative Strength Index) is 72.49 on the 14-day chart, showing overbought technical sentiment.
Is BeOne Medicines Ltd ADR subject to short interest?
Stocks of BeOne Medicines Ltd ADR saw a sharp steep in short interest on 2025-05-30 dropping by 53390.0 shares to 2.03 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 2.08 million shares. A decline of -2.63% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.55 of the overall float, the days-to-cover ratio (short ratio) decline to 5.55.
